Clinical Trial

Transvaginal Sacrospinous Hysteropexy Versus Laparoscopic Uterine Lateral Suspension

Recruiting
View on ClinicalTrials.gov →
Summary
Transvaginal or transabdominal surgeries are current choices of uterus-preserving surgeries for pelvic organ prolapse. Laparoscopic lateral uterine suspension, a modified surgical approach of uterine suspension from bilateral abdominal wall fascia, performed with expected safety and simplicity of surgery besides advantages including small wound incision and fast recovery in laparoscopic surgeries. This trial aim to discuss the therapeutic efficacy, long term safety, and adverse events of laparoscopic lateral uterine suspension and compare with the conventional transvaginal sacrospinous ligament fixation with native tissue repair.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-10-16.
Trial Details
NCT Number NCT05586984
Lead Sponsor National Cheng-Kung University Hospital
Conditions Pelvic Organ Prolapse, Uterine Prolapse
Enrollment 90 participants
Start Date 2022-07-26
Primary Completion 2029-12-31 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2022-10-21